Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Us TOO University Patient Education Webinar and Teleconference:

Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Treatment for Prostate Cancer

Made possible by a contribution from GTx, Inc.

Originally held September 23, 2009

Watch and listen to webinar here | Read transcript here | View slides here (PDF)


7:00 pm Welcome and introductions, Pam Barrett, Director of Development, Us TOO International
7:04 pm
Presentation by Dr. Taneja begins:
  • How ADT affects men treating prostate cancer
  • The role of estrogen and testosterone in men, and deficiencies associated with ADT
  • Key points on ADT estrogen deficiency side effects
  • Key points in managing estrogen deficiency side effects of ADT
7:28 pm Q&A begins
7:48 pm Wrap-up begins
7:50 pm Call/webinar ends

Featured speaker:

Samir Teneja, MD

Dr. Taneja is an Associate Professor of Urologic Oncology with the New York University Langone Medical Center.

He graduated from Northwestern University School of Medicine in 1990, completed his surgical and urologic training at the University of California at Los Angeles in 1996, and then joined the faculty of New York University where he completed a post-doctoral fellowship in the study of hormonal regulation of prostate cancer growth. He has been the Director of Urologic Oncology in the Department of Urology and NYU Cancer Institute since 2000, Director of the Sherman Fellowship in Urologic Oncology since 2006, and Chief of Urology at the Veterans Administration New York Harbor Healthcare System, Manhattan campus since 2008. In 2006, he was awarded an endowed professorship in urologic oncology.

Dr. Taneja's clinical practice is focused in the care of prostate cancer patients. He has specific expertise in nerve-sparing radical prostatectomy, with clinical interests in prostate cancer diagnosis, prevention, and the management of high risk and advanced disease. He has been listed among New York Magazine's Best Doctors, and Castle and Connolly's America's Top Doctors for Cancer.

Dr Taneja’s laboratory research, focused in understanding how hormones regulate prostate cancer growth, has been funded by the National Institutes of Health, the Department of Defense, and a number of private foundations. He also oversees a number of clinical trials of prevention and treatment. His most recent research interest is in developing strategies of mapping prostate cancer for focal therapy.

Dr. Taneja has authored more than 150 articles and book chapters, edited 2 textbooks, and lectured throughout the world on urologic cancer. Dr. Taneja is host of the weekly Men’s Health Show on Sirius/XM satellite radio.